The elevated TRIM21 and TRIM25 levels in liver cancer patients (Fig 7A) and the increased hazard ratio in patient groups with high TRIM21 and TRIM25 expression (Fig 7B) indicates the association of these TRIM proteins and vtRNA1-1 levels with tumor progression. Here, TRAT1 is linked to liver cancer.